Scienture Holdings, Inc. (NASDAQ: SCNX), a Tampa-based pharmaceutical innovator specializing in cardiovascular and central nervous system (CNS) therapies, has announced plans for a $250...
Cantor Equity Partners V, the fifth blank-check company formed by Cantor Fitzgerald, priced its upsized $220 million initial public offering, signaling a continued revival...
Westin Acquisition Corp., a newly formed special-purpose acquisition company (SPAC), has successfully priced its $50 million initial public offering, marking another strategic entry into...